农艺学和Onego Bio：FDA GreenlightsBioalbumen® - 卵子蛋白的新时代？

Onego Bio的Bioalbumen®获得了FDA的点头，为可持续卵蛋白铺平了道路。验证了农艺学的投资策略，这表明食品技术的重大转变。

Hold onto your hats, folks! The food tech world is buzzing about the latest developments with Agronomics and Onego Bio. Let's dive into what's cracking (pun intended!).

抓住你的帽子，伙计们！食品技术界正在欣赏农艺学和Onego Bio的最新发展。让我们深入了解什么是破裂（双关语！）。

FDA Gives Thumbs Up to Onego Bio's Bioalbumen®

FDA对Onego Bio的Bioalbumen®表示赞许

Big news out of Onego Bio, an Agronomics portfolio company: The FDA has issued a "no questions" letter regarding the Generally Recognized As Safe (GRAS) status of their Bioalbumen®. This means their egg protein alternative, made through precision fermentation, is good to go for use in a wide range of food and beverage applications. We're talking baked goods, beverages, even meat analogs – the possibilities are endless!

一家农艺学投资组合公司Onego Bio的大新闻：FDA发布了一封“无问题”信，内容涉及其Bioalbumen®的普遍认可的安全（GRAS）状态。这意味着他们的卵蛋白替代品是通过精确发酵制成的，很适合在各种食品和饮料应用中使用。我们正在谈论烘焙食品，饮料甚至肉类类似物 - 可能性无限！

What's the Big Deal About Bioalbumen®?

Bioalbumen®有什么大不了的？

Bioalbumen® isn't just another egg substitute; it's a game-changer. Made with the filamentous fungus Trichoderma reesei, this ovalbumin protein mirrors the amino acid sequence found in chicken eggs. That means it offers the same high-quality nutrition and functionality as traditional egg protein. Think of it as the eco-friendly, supply-chain-secure cousin of the eggs we already know and love.

Bioalbumen®不仅是另一个鸡蛋替代品；这是一个改变游戏规则的人。这种卵巢蛋白蛋白采用丝状真菌trichoderma reesei制成，反映了在鸡蛋中发现的氨基酸序列。这意味着它提供了与传统卵子蛋白相同的高质量营养和功能。将其视为我们已经知道和喜欢的鸡蛋的环保，供应链安全的表弟。

Wisconsin on the Horizon

威斯康星州

Onego Bio isn't stopping at just getting the FDA's approval. They're planning to build their flagship production facility in Jefferson County, Wisconsin. This move is set to scale up Bioalbumen® manufacturing to meet the ever-increasing demand. The location of this production facility in Wisconsin signals Onego Bio's confidence in their U.S. operations.

Onego Beio并没有停止仅获得FDA的批准。他们计划在威斯康星州杰斐逊县建立旗舰生产设施。这一举动旨在扩大Bioalbumen®制造业，以满足不断增长的需求。威斯康星州该生产设施的位置表明，Onego Bio对其美国业务的信心。

Agronomics' Investment Pays Off

农艺学的投资有偿

Agronomics has invested £7.1 million in Onego Bio, and that position is currently valued at £11.2 million. That's roughly 7.5% of Agronomics' Net Asset Value as of June 30, 2025. Jim Mellon, Executive Chairman of Agronomics, believes this milestone can drive job creation and economic growth, as well as answer the need from manufacturers for a sustainable ingredient that bolsters supply chain security.

农艺学已向Onego Bio投资了710万英镑，该职位目前的价值为1,120万英镑。截至2025年6月30日，这是农艺学净资产价值的7.5％。农艺学执行董事长吉姆·梅隆（Jim Mellon）认为，这一里程碑可以推动创造就业机会和经济增长，并回答制造商对可持续成分的需求，以增强可持续成分，以增强供应链的可持续成分。

Why This Matters

为什么这很重要

In a world where avian flu and extreme weather events are increasingly threatening our food supply chains, Bioalbumen® offers a much-needed solution. By supplementing the industrial egg supply, we can better defend against disruptions and ensure food security for everyone.

在一个鸟类流感和极端天气事件越来越威胁到我们的食品供应链的世界中，Bioalbumen®提供了急需的解决方案。通过补充工业鸡蛋供应，我们可以更好地防御中断，并确保为所有人提供粮食安全。

Looking Ahead

展望未来

The FDA's thumbs-up is a significant step forward for Onego Bio and the clean food industry. With plans to scale up production in Wisconsin and Agronomics' continued support, Bioalbumen® is poised to make a real impact on the way we produce and consume food.

对于Onego Beio和Clean Food行业来说，FDA的大拇指是向前迈出的重要一步。随着计划扩大威斯康星州的生产和农艺学的持续支持，Bioalbumen®有望对我们生产和食用食物的方式产生真正的影响。

So, next time you're enjoying a delicious cake or a frothy latte, remember that the future of food might just be a little bit more sustainable, thanks to companies like Onego Bio and Agronomics. Who knew saving the world could taste so good?

因此，下次您享受美味的蛋糕或泡沫拿铁咖啡时，请记住，由于Onego Bio和Agronomics等公司，食物的未来可能会更可持续。谁知道拯救世界的品味会这么好？